Name

Omacetaxine

Alternate Names

Homoharringtonine
Omacetaxine mepesuccinate
Omapro
Synribo

Abbreviations

INN

Category

Chemotherapy

Subcategory

Alkaloid
Protein inhibitor

NSC Number

102816

Primary Site

Acute lymphoblastic leukemia (ALL)
Myelodysplastic syndrome (MDS)

Histology

None

Remarks

Approved under the FDA's accelerated approval program October 26, 2012 to treat CML.

Coding

This drug should be coded
Glossary